Wednesday, September 2, 2026

UnitedHealthcare will eliminate prior authorization requirements for roughly 1,700 services, effective October 1, 2026. This applies to a range of conditions, including certain orthopedic, cardiology, and gastroenterology procedures. The change aims to streamline administrative burdens. For practices contracted with UHC, review your October 1 scheduled services against the new list. Confirm the specific procedure codes and services covered under this policy via UHC's provider portal to avoid unnecessary pre-certification requests and delays. This action is required; update your workflow by the effective date.

Texas Attorney General Ken Paxton opened an investigation into TriWest Healthcare Alliance for allegedly wrongfully denying TRICARE claims. The probe examines whether TriWest's practices violated state consumer protection laws regarding military families' healthcare coverage. For practices serving TRICARE patients through TriWest, monitor the investigation's findings for potential shifts in denial patterns or appeal requirements. Document all TRICARE claim denials and appeal decisions meticulously. The outcome could influence TriWest's internal review processes and create new appeal opportunities for previously denied claims.

Genesis Health System in Ohio stated it may terminate contracts with four unnamed insurers due to a backlog of approximately 9,000 denied claims. The system cites unsustainable administrative costs and revenue cycle strain from high denial volumes as the reason for the potential network exits. This signals increasing provider pushback against payer denial practices. While specific to one health system, it reflects a broader trend of providers reassessing payer relationships based on operational friction. Monitor your own denial rates by payer; a concentrated spike may indicate a systemic issue warranting contract renegotiation.

A growing number of U.S. employers are excluding GLP-1 drugs for weight loss from their 2027 health benefit plans. This trend, reported September 1, is a direct response to soaring drug costs that are projected to increase overall healthcare spending by up to 10%. For medical practices, this means more patients presenting for obesity or diabetes management may discover their GLP-1 prescriptions are no longer covered, shifting the conversation to cash pay or alternative therapies. Front office and clinical staff should prepare for increased patient inquiries about coverage verification and prior authorization requirements as 2027 plan years approach.